Table 2.
Variable | Baseline |
Post-Treatment |
Between-Group Effects |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
IMCP(n = 40) |
TM(n = 37) |
IMCP(n = 40) |
TM(n = 37) |
||||||||||
Mean | SD | Mean | SD | Mean | SD | Within-Group d | Mean | SD | Within-Group d | Difference | 95% CI | P | |
SWB | 2.22 | 0.82 | 2.46 | 0.76 | 2.72 | 0.83 | 0.60 | 2.52 | 0.68 | 0.08 | 0.39 | 0.17 to 0.61 | < .001 |
SWB-M | 2.49 | 0.76 | 2.64 | 0.73 | 2.98 | 0.69 | 0.68 | 2.72 | 0.65 | 0.12 | 0.34 | 0.12 to 0.56 | .003 |
SWB-F | 1.70 | 1.27 | 2.12 | 1.19 | 2.15 | 1.38 | 0.35 | 2.14 | 1.21 | 0.02 | 0.42 | 0.04 to 0.80 | .03 |
BHS | 7.58 | 4.38 | 6.38 | 4.67 | 4.70 | 4.04 | −0.68 | 5.03 | 4.59 | −0.29 | −0.93 | −2.54 to 0.68 | .3 |
MQOL | 5.89 | 1.65 | 6.55 | 1.70 | 7.18 | 1.45 | 0.83 | 6.78 | 1.55 | 0.14 | 0.76 | 0.17 to 1.35 | .013 |
HADS-D | 2.09 | 0.61 | 1.85 | 0.49 | 1.98 | 0.29 | −0.23 | 1.97 | 0.27 | 0.30 | −0.02 | −0.13 to 0.10 | .8 |
HADS-A | 2.39 | 0.61 | 2.14 | 0.60 | 2.24 | 0.23 | −0.31 | 2.19 | 0.21 | 0.12 | 0.03 | −0.08 to 0.14 | .6 |
MSAS-Sx | 18.73 | 7.10 | 17.32 | 8.18 | 16.00 | 8.19 | −0.36 | 19.70 | 7.98 | 0.29 | −6.56 | −9.83 to −3.30 | < .001 |
MSAS-Di | 1.95 | 0.71 | 1.67 | 0.77 | 1.53 | 0.70 | −0.59 | 1.76 | 0.75 | 0.12 | −0.47 | −0.72 to −0.21 | < .001 |
2-Month Follow-Up |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
(n = 33) | (n = 34) | ||||||||||||
SWB | 2.22 | 0.82 | 2.46 | 0.76 | 2.60 | 0.78 | 0.56 | 2.54 | 0.78 | 0.22 | 0.20 | −0.11 to 0.51 | .2 |
SWB-M | 2.49 | 0.76 | 2.64 | 0.73 | 2.78 | 0.67 | 0.55 | 2.77 | 0.76 | 0.29 | 0.09 | −0.22 to 0.40 | .6 |
SWB-F | 1.70 | 1.27 | 2.12 | 1.19 | 2.25 | 1.38 | 0.43 | 2.08 | 1.20 | 0.05 | 0.45 | −0.01 to 0.90 | .054 |
BHS | 7.58 | 4.38 | 6.38 | 4.67 | 4.84 | 3.98 | −0.69 | 4.91 | 4.25 | −0.39 | −0.58 | −2.35 to 1.20 | .5 |
MQOL | 5.89 | 1.65 | 6.55 | 1.70 | 6.88 | 1.42 | 0.76 | 6.86 | 1.74 | 0.25 | 0.36 | −0.34 to 1.07 | .3 |
HADS-D | 2.09 | 0.61 | 1.85 | 0.49 | 1.89 | 0.52 | −0.44 | 1.77 | 0.50 | −0.23 | −0.02 | −0.23 to 0.19 | .9 |
HADS-A | 2.39 | 0.61 | 2.14 | 0.60 | 2.16 | 0.57 | −0.43 | 2.18 | 0.51 | −0.06 | −0.13 | −0.34 to 0.08 | .2 |
MSAS-Sx | 18.73 | 7.10 | 17.32 | 8.18 | 17.53 | 7.77 | −0.16 | 17.42 | 8.43 | 0.06 | −0.85 | −4.36 to 2.66 | .6 |
MSAS-Di | 1.95 | 0.71 | 1.67 | 0.77 | 1.85 | 0.75 | −0.59 | 1.68 | 0.84 | 0.03 | −0.05 | −0.39 to 0.29 | .8 |
NOTE. Within-group changes are standardized by dividing through by standard deviation (SD); between-group changes are given in terms of the measurement scale.
Abbreviations: BHS, Beck Hopelessness Scale; HADS-A, Hospital Anxiety and Depression Scale, Anxiety subscale; HADS-D, HADS, Depression subscale; IMCP, Individual Meaning-Centered Psychotherapy; MQOL, McGill Quality of Life Scale; MSAS-Di, Memorial Symptom Assessment Scale, Global Distress Index; MSAS-Sx, MSAS, Symptom Burden; SD, standard deviation: SWB, Functional Assessment of Chronic Illness Therapy, Spiritual Well-Being Scale; SWB-F, SWB, Faith subscale; SWB-M, SWB, Meaning/Peace subscale; TM, therapeutic massage.